Updates in Inflammatory Bowel Disease 2025

Registration Information

Need Help?

Course Chairs

Uma Mahadevan, MD
Lynne and Marc Benioff Professor of Gastroenterology,
Director, UCSF Colitis and Crohn’s Disease Center

Fernando Velayos, MD, MPH
Professor of Medicine, University of California, San Francisco 
Director of Inflammatory Bowel Disease, Northern California Kaiser

Michael Kattah, MD, PhD
Assistant Professor of Medicine
Division of Gastroenterology

Overview

The UCSF Colitis and Crohn’s Disease Center is dedicated to providing comprehensive care for individuals with Crohn's disease, ulcerative colitis, and related illnesses. As part of this commitment, we are proud to present our twentieth inflammatory bowel disease (IBD) symposium. This course will address advances in the medical and surgical management of Crohn's disease and ulcerative colitis including novel therapies and optimizing current medications. Management of special populations including the pregnant patient and those with complications of therapy will be discussed. This year’s course also includes a workshop on Intestinal Ultrasound for IBD.

Who Should Attend This Course?
This symposium is designed for gastroenterologists, colorectal surgeons, internists, and other health professionals who participate in the management of this complicated patient population.

Objectives

Upon completion of this course, attendees will refine their approaches to:

• Correct choice of therapy and adequate monitoring of therapy efficacy among patients with IBD
• Appropriately utilize novel diagnostics including intestinal ultrasound
• The unique challenges for special populations in IBD - pregnant patients, older patients, and LGBTQ patients
• Endpoints of therapy for IBD
• Discussing and incorporating novel therapies and biosimilars with their patients
• Appropriately prescribing dietary therapy for IBD

Accreditation

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
UCSF designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity. This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants
AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 credit™ for the PRA for organizations accredited by the ACCME.